Evidence map›Paper›PMID 38442134›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2024

Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations.

Paul Jones, Toru Soutome, Taizo Matsuki, Masahiro Shinoda, Osamu Hataji, Motohiko Miura, Masaharu Kinoshita, Akira Mizoo, Kazunori Tobino, Takanobu Nishi and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Observational
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Paul JonesGSK, Brentford, Middlesex, United Kingdom.
Toru SoutomeJapan Medical and Development, GSK K.K, Tokyo, Japan.
Taizo MatsukiJapan Medical and Development, GSK K.K, Tokyo, Japan.
Masahiro ShinodaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo, Japan.
Osamu HatajiRespiratory Center, Matsusaka Municipal Hospital, Matsusaka, Mie, Japan.
Motohiko MiuraDepartment of Respiratory Medicine, Tohoku Rosai Hospital, Miyagi, Japan.
Masaharu KinoshitaDepartment of Respiratory Medicine, Nagata Hospital, Fukuoka, Japan.
Akira MizooDepartment of Pulmonary Medicine, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Tokyo, Japan.
Kazunori TobinoDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.
Takanobu NishiJapan Medical and Development, GSK K.K, Tokyo, Japan.
Takeo IshiiJapan Medical and Development, GSK K.K, Tokyo, Japan.
Yoko ShibataDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Aso Iizuka Hospital · JPFukuoka Hospital · JPFukushima Medical University · JPJapan Community Healthcare Organization · JPNew Tokyo Hospital · JPSoka Municipal Hospital · JPTohoku Rosai Hospital · JPWest Middlesex University Hospital · GB

Funding

GSK 212648/HO-19-19947
6 · The paper itself

Abstract

Background: A previous longitudinal study of chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) score changes suggested patients fall into 3 patterns: stable, improving, and worsening. This study assessed the evolution of CAT scores over time and its relationship to exacerbations. Methods: In total, 84 participants used a telemedicine platform to complete CAT weekly for 52 weeks. Completion rates, annualized change in CAT scores, and learning effects were measured, as well as CAT changes of >4 units during look-back periods of 4 and 8 weeks. In a subgroup of participants with at least a 25% completion rate (adherent group, n=68 [81%]), the relationship between change in CAT score and exacerbations at any time during the study was examined post hoc. Results: Linear regression showed that 50%, 22%, and 28% of the adherent subgroup had CAT scores indicating worsening, stable, and improving health status, respectively. In the adherent subgroup, 70% (n=7/10) of participants who had an exacerbation during the study had worsening CAT scores, versus 47% (n=27/58) without an exacerbation. The hazard ratio association between CAT score increase and moderate exacerbation was 1.13 (95% confidence interval: 1.03-1.24). Most participants experienced at least one CAT score change of >4 units, and 7% showed an initial learning effect with a median of 2 weeks. Conclusion: Measuring trends in CAT scores may allow future studies to group patients into 3 defined categories of change over time and quantify CAT change trajectories to assess treatment response and potentially predict medium-term outcomes within individual patients.

Indexed as

CAT scoreCOPDexacerbationspatient-reported outcometelemonitoring

Identifiers

PMID38442134
PMCPMC11075351
OpenAlexW4392208138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.